This week in Washington: COVID-19 relief bill negotiations begin in earnest; Congress works on Appropriations bills hoping to have them passed before government funding ends on Dec. 11....more
This week in Washington: House Minority Leader Kevin McCarthy announced he is waiting to see who will become the next House speaker before working on another COVID-19 stimulus package; Senate Appropriations Committee releases...more
11/17/2020
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
GAO ,
Health Care Providers ,
Health Insurance ,
Hospitals ,
Interim Final Rules (IFR) ,
Medicaid ,
Physicians ,
Trump Administration
Upcoming Hearings -
Tuesday, March 5, 2019 -
Senate Committee on Health, Education, Labor and Pensions (HELP): “Vaccines Save Lives: What is Driving Preventable Disease Outbreaks?” -
The Senate Committee on Health,...more
3/5/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Medicare ,
OMB ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs
Upcoming Hearings -
Tuesday, Feb. 26, 2019 -
Senate Finance Committee: “TBA Hearing on Drug Pricing” -
The second hearing in a series on drug pricing in the Senate Finance Committee will include the testimonies of...more
2/19/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Health Care Providers ,
Medicare ,
Medicare Part D ,
OMB ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trump Administration
This Week: Happy New Year! The 116th Congress begins and healthcare issues are part of the "buzz" of day one. Part of the government is still closed. ...more
1/8/2019
/ ACOs ,
Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Medicaid ,
Medicare ,
Prescription Drugs ,
Proposed Rules ,
Section 340B ,
Trump Administration